Home › Funds › RA CAPITAL MANAGEMENT, L.P. › ABOS
RA CAPITAL MANAGEMENT, L.P. position in ABOS
ACUMEN PHARMACEUTICALS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 20,992,669 shares of ABOS (ACUMEN PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$56.1M, representing 0.49% of its reported portfolio and ranking #38 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed ABOS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s ABOS position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in ABOS in Q3 2023 at 14,932,063 shares (US$62.0M). Across 12 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 20,992,669 shares valued at US$56.1M. Notable position changes include a 41% increase in Q1 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 14.93M | $61.97M | New |
| Q4 2023 | 14.93M | $57.34M | Hold |
| Q1 2024 | 14.93M | $60.47M | Hold |
| Q2 2024 | 14.93M | $36.14M | Hold |
| Q3 2024 | 14.93M | $37.03M | Hold |
| Q4 2024 | 14.93M | $25.68M | Hold |
| Q1 2025 | 14.93M | $16.43M | Hold |
| Q2 2025 | 14.93M | $17.32M | Hold |
| Q3 2025 | 14.93M | $25.53M | Hold |
| Q4 2025 | 14.93M | $31.51M | Hold |
| Q1 2026 | 20.99M | $49.54M | Add |
| Q2 2026 | 20.99M | $56.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABOS and 13F data
ABOS (ACUMEN PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in ABOS — the largest reported positions include Sands Capital Alternatives, LLC (US$9.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABOS
- Sands Capital Alternatives, LLC 3.72M sh · $9.93M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held ABOS?
RA CAPITAL MANAGEMENT, L.P. has disclosed ABOS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in ABOS?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 20.99M shares of ABOS (ACUMEN PHARMACEUTICALS INC), valued at $56.05M, representing 0.49% of its reported portfolio and ranking #38.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling ABOS?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in ABOS.
Which other funds hold ABOS?
Other major institutional holders of ABOS include Sands Capital Alternatives, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.